TECHBio-Techne Corporation
48.10USD-0.23%Mkt Cap: 7.54B USDP/E: 68.82Last update: 2026-05-26

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company o…

Indicators:|

Key Statistics

Company
Market Cap7.54B USD
Enterprise Value7.49B USD
Revenue (TTM)1.21B USD
Gross Profit790.27M USD
Net Income (TTM)73.40M USD
Revenue/Share7.769 USD
Last Price48.10 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees3.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS09073M1045
Valuation
P/E (Trailing)68.82
P/E (Forward)22.95
PEG0.64
EV/EBITDA20.47
EV/Revenue6.19
P/S6.13
P/B3.67
EPS (TTM)0.70
EPS (Forward)2.06
52W Range
43.2017% of range72.16
52W High72.16 USD
52W Low43.20 USD
Profitability
Gross Margin64.80%
Oper. Margin25.19%
EBITDA Margin30.23%
Profit Margin6.02%
ROE3.83%
ROA2.87%
Growth
Revenue Growth-1.50%
Earnings Growth128.60%
Cash Flow & Leverage
Operating CF287.56M USD
CapEx (TTM)31.01M USD
FCF Margin24.76%
FCF Yield3.98%
Net Debt76.21M USD
Net Debt/EBITDA0.21
Balance Sheet
Debt/Equity0.23
Current Ratio4.49
Quick Ratio2.80
Book Value/Sh12.90 USD
Cash/Share1.368 USD
Dividends
Fwd Div Rate0.3200 USD
Trail. Div Rate0.3200 USD
Div. Yield0.68%
5Y Avg Yield0.43%
Payout Ratio45.71%
Ex-Div DateMay 18, 2026
Pay DateMay 29, 2026
Splits
Last Split4:1
Split DateNov 30, 2022
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)61.42 USD
Target Range49.00 USD75.00 USD
# Analysts12
Ownership
Shares Out.156.57M
Float154.66M
Insiders0.30%
Institutions117.97%
Short Interest
Short Ratio6.6d
Short % Float9.72%
Short % Out.8.52%
Shares Short13.34M
Short (prev mo.)14.10M
Technical
SMA 5052.38 (-8.2%)
SMA 20057.61 (-16.5%)
Beta1.41
S&P 52W Chg28.31%
Avg Vol (30d)2.92M
Avg Vol (10d)3.35M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)